Project description
Ukraine creates a Centre of Excellence in analytical biotechnology
The Institute of Molecular Biology and Genetics (IMBG) of the National Academy of Sciences of Ukraine is one of the country's leading institutions in life sciences research. The IMBG has an exemplary programme in analytical biotechnologies, a field that uses cutting-edge technologies to drive biological macromolecules as supersensitive receptors and signal transducers for a variety of analysing applications. The EU-funded BIONANOSENS project, focused on the development of novel biomolecular electronics for analytical bionanotechnology, is twinning the IMBG with EU partners to build the Institute's capacity and create an internationally renowned Centre of Excellence in analytical biotechnologies. The Institute's world-class scientists will benefit also in areas ranging from proposal writing and grant management to networking and mentoring young scientists, complementing the existing scientific expertise with the skills to keep research funds and new talents flowing in.
Objective
The Institute of Molecular Biology and Genetics (IMBG) is one of the leading research centres in Ukraine in the field of analytical biotechnology, with a great potential for the development of market-driven innovations. With the support of high-profile research and innovation (R&I) institutes from Europe, which, together with IMBG form the BIONANOSENS consortium, the Ukrainian institute should be positioned as an international Centre for Excellence in analytical biotechnology also beyond national borders. BIONANOSENS implements tailor-made twinning actions helping to build and strengthen capacities at the beneficiary’s end. Both the overall goal and the single objectives related to it (to establish institutional grant management procedures, better access to international networks, project proposal writing services, promotion and training of young researchers, service and facilitation to the dissemination and exploitation of research results etc.) are taking into full account IMBG’s current operational situation. BIONANOSENS further exploits the findings of a SWOT analysis, which was conducted for IMBG from 2012 to 2013 as part of the COMBIOM project (FP7). All activities are carried out against the state-of-the-art standards in managing EU funded R&I projects – including Responsible Research and Innovation, gender balance, open access (data management, Intellectual Property management), exploitation and commercialisation orientation, and ethics.
Keywords
Programme(s)
- H2020-EU.4.b. - Twinning of research institutions Main Programme
Topic(s)
Funding Scheme
CSA - Coordination and support actionCoordinator
03680 Kyiv
Ukraine